Pharmacology & ToxicologyPharmacological ReportsPeer-reviewed
PERK inhibition with GSK2606414 in zebrafish evokes developmental defects consistent with Wolcott-Rallison syndrome phenotypes
Liliana M. Almeida, Leonor Pereira Lima, Nuno A. S. Oliveira…·Jorge M. A. Oliveira
This study uses zebrafish to model Wolcott-Rallison syndrome by inhibiting PERK with GSK2606414, revealing developmental defects consistent with the syndrome.